Light AI

Vancouver-based Light AI has partnered with MrBeast Industries to donate AI-powered Strep A tests to underserved communities in Africa. The initiative, featured in a Beast Philanthropy video released on February 16, 2025, aims to improve early detection of Strep A, a bacterial infection linked to Rheumatic Heart Disease (RHD), which causes up to 350,000 deaths annually.

Light AI CEO Peter Whitehead highlighted the technology’s potential to provide instant, accurate diagnoses, while Jimmy Donaldson (MrBeast) emphasized its life-saving impact. The project showcases the power of AI-driven healthcare solutions in addressing global health challenges.

Want to know more? Check out the source code on Techcouver.

Vancouver-based Light AI launched on Cboe Canada, trading under ALGO, aiming to revolutionize medical diagnostics. Armed with $20 million in R&D since 2016, its AI algorithms analyze smartphone images to detect Strep A infections, eliminating the need for traditional swabbing. Pre-FDA studies show a 97% accuracy rate, equivalent to swabs.

CEO Peter Whitehead envisions expanding the AI-powered tech to other conditions like skin and eye disorders. Light AI’s 300,000-image pharyngitis database underpins its technology, touted as a step toward a “Digital Clinical Lab” offering rapid, accessible diagnoses.

Want to know more? Check out the source code on Techcouver.